NVCR
NovoCure Limited Ordinary Shares
$14.19
0.00%
0.00
Notify me if price changes either direction
Buy NVCR stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
1.6B
Enterprise value
1.2B
Trailing PE
-9.0961535771688
Forward PE
-8.743291
PEG Ratio
-0.50938460032145
Enterprise to EBITDA
-7.671
Enterprise to revenue
1.902
Price to book MRQ
4.2700133
Price to sales TTM
2.2692134
Financials
Fiscal Year Ends
2024-12-31
Most Recent Quarter (MRQ)
2025-09-30
Revenue (TTM)
642.3M
EBITDA
-159287008
Diluted EPS TTM
-1.61
Total Cash (MRQ)
1.0B
Current ratio (MRQ)
1.546
Operating Cash Flow (TTM)
-34478000
NVCR trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
January 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
